These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1459975)

  • 1. High incidence of haloperidol decanoate injection site reactions.
    Reinke M; Wiesert KN
    J Clin Psychiatry; 1992 Nov; 53(11):415-6. PubMed ID: 1459975
    [No Abstract]   [Full Text] [Related]  

  • 2. Haloperidol decanoate: injection site reactions.
    Maharaj K; Guttmacher LB; Moeller R
    J Clin Psychiatry; 1995 Apr; 56(4):172-3. PubMed ID: 7713859
    [No Abstract]   [Full Text] [Related]  

  • 3. Injection site reactions after intramuscular administration of haloperidol decanoate 100 mg/mL.
    Hamann GL; Egan TM; Wells BG; Grimmig JE
    J Clin Psychiatry; 1990 Dec; 51(12):502-4. PubMed ID: 1979555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Injection site reactions.
    Hay J
    J Clin Psychiatry; 1992 Jul; 53(7):256. PubMed ID: 1353493
    [No Abstract]   [Full Text] [Related]  

  • 5. [Haloperidol decanoate: results of a 6-month open trial in paranoid schizophrenia].
    Pérez C; Stier Rosner SE
    Acta Psiquiatr Psicol Am Lat; 1989; 35(3-4):111-5. PubMed ID: 2576990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses.
    Roose K
    Acta Psychiatr Belg; 1982; 82(2):216-23. PubMed ID: 7180558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A practical loading dose method for converting schizophrenic patients from oral to depot haloperidol therapy.
    Wei FC; Jann MW; Lin HN; Piao-Chien C; Chang WH
    J Clin Psychiatry; 1996 Jul; 57(7):298-302. PubMed ID: 8666571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of the efficacy of haloperidol decanoate].
    Alvarez JV; Li Gambi M
    Acta Psiquiatr Psicol Am Lat; 1986 Sep; 32(3):233-6. PubMed ID: 2884807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clinical trial comparing intramuscular haloperidol decanoate and oral haloperidol in chronic schizophrenic patients: efficacy, safety, and dosage equivalence.
    Vasavan Nair NP; Suranyi-Cadotte B; Schwartz G; Thavundayil JX; Achim A; Lizondo E; Nayak R
    J Clin Psychopharmacol; 1986 Feb; 6(1 Suppl):30S-37S. PubMed ID: 3514689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia.
    Chouinard G; Annable L; Campbell W
    J Clin Psychopharmacol; 1989 Aug; 9(4):247-53. PubMed ID: 2570086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intramuscular haloperidol decanoate for neuroleptic maintenance therapy.
    arap Mengech HN; Wazome EG
    East Afr Med J; 1984 Jun; 61(6):435-8. PubMed ID: 6152736
    [No Abstract]   [Full Text] [Related]  

  • 12. Dosage strategies with long-acting injectable neuroleptics, including haloperidol decanoate.
    Kane JM
    J Clin Psychopharmacol; 1986 Feb; 6(1 Suppl):20S-23S. PubMed ID: 2870088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haloperidol decanoate in the treatment of schizophrenia.
    Zapletálek M; Zbytovský J
    Act Nerv Super (Praha); 1989 Apr; 31(1):39-41. PubMed ID: 2571224
    [No Abstract]   [Full Text] [Related]  

  • 14. Excretion and metabolism of intramuscularly administered [14C]-haloperidol decanoate in rats.
    Matsunaga Y; Nambu K; Oh-e Y; Miyazaki H; Hashimoto M
    Arzneimittelforschung; 1986 Mar; 36(3):453-6. PubMed ID: 3707664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed onset of oculogyric crisis and torticollis with intramuscular haloperidol.
    Jhee SS; Zarotsky V; Mohaupt SM; Yones CL; Sims SJ
    Ann Pharmacother; 2003 Oct; 37(10):1434-7. PubMed ID: 14519055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haloperidol decanoate in children.
    Alessi N; Alkhouri I; Fluent T; Quinlan P; Williams K
    J Am Acad Child Adolesc Psychiatry; 2001 Aug; 40(8):865-6. PubMed ID: 11501680
    [No Abstract]   [Full Text] [Related]  

  • 17. Haloperidol decanoate pharmacokinetics in red blood cells and plasma.
    Dysken MW; Kim SW; Vatassery G; Johnson SB; Skare S; Holden L; Thomsyck L
    J Clin Psychopharmacol; 1992 Apr; 12(2):128-32. PubMed ID: 1573034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haloperidol decanoate in schizophreniform disorders. Clinical and neuroendocrine aspects.
    Meco G; Casacchia M; Attenni M; Iafrate A; Castellana F; Ecari U
    Acta Psychiatr Belg; 1983; 83(1):57-68. PubMed ID: 6613612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Open clinical trial with haloperidol decanoate in patients with psychotic disorders].
    Ellerman LA
    Acta Psiquiatr Psicol Am Lat; 1987 Jun; 33(2):157-62. PubMed ID: 3321918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Accidental intravenous administration of haloperidol decanoate].
    Heinz P
    Psychiatr Prax; 1996 Jan; 23(1):42. PubMed ID: 8851235
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.